Navigation Links
HCL Supports Reform of Language Testing for International Doctors
Date:6/30/2010

Company stresses that all its international doctors meet or exceed all required qualifications and language competency.

London, UK (PRWeb UK) June 30, 2010 -- HCL plc, one of the UK’s leading health and social care staffing companies, today welcomed the British Medical Association’s calls for a review of the processes which overseas doctors must undergo before they can work in the NHS – but stressed that the NHS relies on overseas professionals and so highly qualified and talented international doctors should not be discriminated against.

Overseas professionals, especially nurses, doctors and allied health professionals, make up a significant proportion of NHS frontline services. For example, General Medical Council figures show that more than 91,000 of the UK’s 243,900 registered doctors gained their medical qualification outside Britain.

Kate Bleasdale, Executive Vice Chairman of HCL plc, commented: “Demographic trends suggest that the NHS will need more, not less, overseas workers in coming years. The UK population is ageing and will need more frequent and acute care – we now have more people aged over 65 in the UK than we do under 16, and the number of over-65s is expected to double in the next 20 years. At the same time, our UK healthcare workforce is itself ageing – over a third of the current nursing workforce is expected to retire in the next decade, and there are not enough school leavers entering the caring professions. Whilst we whole-heartedly support initiatives to attract, train and
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. ACP supports announcement of investments in expansion of primary care workforce
2. ESC supports traffic light food labeling vote
3. American College of Physicians supports SGR provision of H.R. 4213
4. Disabled American Veterans Charitable Services Trust Supports OIF/OEF Veterans Battling PTSD
5. New York Construction Accident Attorney, David Perecman, Supports MTA Night Work
6. The Khanna Institute Supports the Watering Seeds Organization
7. AthletiCo Physical and Occupational Therapy Supports Partners in Health Stand with Haiti
8. ORCS Web, Inc Supports ASP .NET 4.0
9. New phase II study supports potential of gs-9450 as new treatment option for steatohepatitis
10. Kinnser Software Supports HH CAHPS Survey Data Export to Three Approved HH CAHPS Survey Vendors
11. New investigation supports correlation between XMRV and prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HCL Supports Reform of Language Testing for International Doctors
HCL Supports Reform of Language Testing for International Doctors
(Date:5/22/2012)... (May 22, 2012) Scientists at Virginia Commonwealth ... closer to developing a new therapy for acute ... agents obatoclax and sorafenib kill leukemia cells much ... are administered individually., Recently published in the journal ... Steven Grant, M.D., Shirley Carter Olsson and Sture ...
(Date:5/22/2012)... 2012) Pushed to the brink of survival, the ... ancient system that has helped organisms cope with internal ... an integral part of this system, heat shock protein ... accommodate the genetic changes and profound disturbances in normal ... theorized that inhibiting HSP90 just might render breast cancer ...
(Date:5/22/2012)... PORTLAND, Ore. Women who are unable to ... lung function of their newborns by taking Vitamin ... Oregon Health & Science University Doernbecher Children,s Hospital. ... affect the lung development of the developing baby, ... risk of asthma," said Cindy McEvoy, M.D., M.C.R., ...
(Date:5/22/2012)... May 22 (HealthDay News) -- The number of liver ... a new study finds. Researchers said one reason ... death has become more commonplace, and many of those ... organs aren,t healthy enough to attempt a transplant. Another ... to a condition known as fatty liver disease, which ...
(Date:5/22/2012)... microfluidic chip to test for latent tuberculosis. They hope ... than current testing for the disease. , "Our assay ... said Ying Liu, a research specialist working with Professor ... Engineering. , The team has already conducted testing of ... States. , About one-third of the world,s population is ...
Breaking Medicine News(10 mins):Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 2Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 3Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 2Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 3Health News:Vitamin C improves lung function in newborns of pregnant smoking women 2Health News:U.S. Liver Transplants Declining 2Health News:New TB test promises to be cheap and fast 2
... Researchers in Germany have developed a new risk assessment ... and patient's risk of cardiac death. , ECG is ... death can be determined and analysed by the computer.The ... to be calculated.// When the programme has completed its ...
... Researchers in France say that the distorting spectacles can ... balance. They think that the spectacles reset the patient's ... to a long-lasitng cure for some postural problems. ... hemisphere may suffer paralysis down their left side and ...
... of starch, previously thought to be just 'empty calories', actually ... Research Organisation (CSIRO), researchers have revealed that resistant starch could ... cancer. , , ... and China have low rates of bowel cancer even though ...
... has now been developed, which makes the process of providing ... , , The device, called Percutaneous ... involves giving artificial respiration to critically ill patients.// , ... the wall of the trachea,the passage leading to the lungs, ...
... is linked with deliquent behaviour of the chilren later ... Delaney-Black, of Children's Hospital of Michigan, the co author ... in comparison to the teetotallers ,women who drank the ... three times more likely to have a child diagnosed ...
... by the National Institutes of Health, showed that at-risk ... reduced their risk of diabetes by 58%, even without ... type 2 diabetes can sharply reduce the odds through ... data from the nation's first major clinical trial to ...
Other Medicine News:
(Date:5/22/2012)... May 22, 2012 Sorbent Therapeutics, Inc. ... renal diseases, presented positive data from its Phase ... of 111 heart failure patients with chronic kidney ... as compared to placebo.    Data ... presented in an oral session at the Annual ...
(Date:5/22/2012)... 22, 2012   AMRI (NASDAQ: ... organization, announced today the appointment of Ian Shott as ... chairman, president and CEO. In this newly created role, ... in Europe, including the company,s site in Wales, United ... team. As the founder of Excelsyn, acquired by AMRI ...
(Date:5/22/2012)... Inc. and AB SCIEX announced today that they have ... Dr. Gary Van Berkel and his colleagues of Oak ... innovator in the field of mass spectrometry and is ... the field.  The agreement provides Prosolia a license to ... based on the liquid micro- junction surface sampling probe ...
Breaking Medicine Technology:Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study 2Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study 3AMRI Announces President for AMRI Europe 2AMRI Announces President for AMRI Europe 3Prosolia and AB SCIEX reach licensing agreement 2Obese Drivers Less Likely to Buckle Up 3A Study 90693 1Obese Drivers Less Likely to Buckle Up 3A Study 90693 2HPV vaccine completion rate among girls is poor getting worse 90691 1HPV vaccine completion rate among girls is poor getting worse 90691 2HPV vaccine completion rate among girls is poor getting worse 90691 3New Published Guidelines to Help Physicians Diagnose and Treat Lupus Kidney Disease 25324 1New Published Guidelines to Help Physicians Diagnose and Treat Lupus Kidney Disease 25324 2
... Ill., March 29, 2007 /PRNewswire-FirstCall/ -- Baxter,International Inc. ... investigational pandemic H5N1 influenza vaccine and,plans to initiate ... in Europe to confirm the study results. , ... candidate,vaccine is highly immunogenic at low doses, and ...
... Valortim-Treated,Animals , PRINCETON, N.J. and ANNAPOLIS, MD., ... a leading monoclonal antibody company, and,PharmAthene, Inc., ... development of biodefense countermeasures, today announced,that Valortim, ... developed for the prevention and treatment of ...
Other Medicine Technology:Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 2Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 3Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 4Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 5Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 2Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 3Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 4Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 5Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 6Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection 7
Angled 30 degree shaft. 13 mm from tip to bend with 2.5 mm hook curved tip. Polished finished. Overall length excluding hub: 35 mm, 1.4 inches....
Binkhorst, length 18 mm....
Army/Navy retractor (set of 2)....
Sharp. 4 mm wide. Hand-Held...
Medicine Products: